» Articles » PMID: 8892715

Bone Mineral Density and Risk of Breast Cancer in Older Women: the Study of Osteoporotic Fractures. Study of Osteoporotic Fractures Research Group

Overview
Journal JAMA
Specialty General Medicine
Date 1996 Nov 6
PMID 8892715
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To test the hypothesis that bone mineral density (BMD) is associated with the risk of developing breast cancer in older women.

Design: Prospective cohort study with mean (SD) follow-up of 3.2 (1.6) years.

Setting: Four clinical centers, one each located in the following areas: Baltimore, Md; Minneapolis, Minn; Portland, Ore; and the Monongahela Valley in Pennsylvania.

Participants: A total of 6854 nonblack women who were 65 years of age or older and enrolled in the Study of Osteoporotic Fractures.

Measurements: Radius and calcaneus BMD by single photon absorptiometry at baseline; hip and spine BMD by dual-energy x-ray absorptiometry 2 years later.

Main Outcome Measure: Breast cancer confirmed by medical record review.

Results: A total of 97 women developed breast cancer. In the multivariate model, adjusting for age, the degree of obesity, and other important covariates, the risk of breast cancer was about 30% to 50% higher per 1 SD increase in BMD (relative risk, distal radius BMD=1.50; 95% confidence interval, 1.16-1.95). The age-adjusted incidence rate of breast cancer per 1000 person-years among women in the lowest quartile of distal radius BMD was 2.46, compared with 5.99 among women with the highest BMD. Women with BMD above the 25th percentile were at 2.0 to 2.5 times increased risk of breast cancer compared with women below the 25th percentile. Results were consistent across all BMD sites.

Conclusions: Bone mineral density predicts the risk of breast cancer in older women. The magnitude of the association is similar to that observed between BMD and all fractures. Our findings suggest a link between 2 of the most common conditions affecting a woman's health. Identifying a common denominator for these conditions should substantially improve our understanding of their etiology and prevention.

Citing Articles

Long-term changes of cognitive impairment among older breast cancer survivors.

Luo J, Schousboe J, Ensrud K, Hendryx M J Cancer Surviv. 2022; 17(6):1760-1768.

PMID: 35624198 DOI: 10.1007/s11764-022-01220-0.


Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.

Fraenkel M, Novack V, Mizrakli Y, Koretz M, Siris E, Norton L NPJ Breast Cancer. 2022; 8(1):21.

PMID: 35177701 PMC: 8854387. DOI: 10.1038/s41523-022-00388-z.


The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone.

Liu C, Hu A, Chen H, Liang J, Gu M, Xiong Y Acta Pharm Sin B. 2022; 12(1):364-377.

PMID: 35127392 PMC: 8799883. DOI: 10.1016/j.apsb.2021.06.012.


A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment.

Lee J, Lee J, Lee J, Kim Z, Han S, Hur S J Breast Cancer. 2021; 24(3):280-288.

PMID: 34128366 PMC: 8250100. DOI: 10.4048/jbc.2021.24.e28.


Effect of gynecological cancer and its treatment on bone mineral density and the risk of osteoporosis and osteoporotic fracture.

Lee J, Park C, Lee E, Ji Y Obstet Gynecol Sci. 2020; 63(4):470-479.

PMID: 32689773 PMC: 7393757. DOI: 10.5468/ogs.20012.